Khure Health, a subsidiary of HEALWELL AI, is proud to announce our contribution to the development of WELL Health‘s new AI-powered co-pilot for cardiologists. This innovative tool leverages Khure’s AI-enabled clinical decision support platform to empower cardiologists across Canada in the early detection and management of cardiovascular disease (CVD) patients.
Cardiovascular disease (CVD) remains the leading cause of death globally, according to the World Health Organization (WHO). In 2019, an estimated 17.9 million people died from CVD, representing a staggering 32% of all global deaths. [1, 2] Early identification of patients at high risk is crucial for preventative care and reducing the burden of this disease. Khure’s AI technology analyzes patient data and provides valuable insights to cardiologists, enabling them to:
- Identify high-risk CVD patients.
- Facilitate early detection and intervention for better patient outcomes.
- Streamline workflows and enhance preventative care strategies.
This collaboration with WELL Health signifies a significant step forward in utilizing AI to support improved cardiovascular care. The co-pilot will be made available to all Cerebum EMR users. Cerebrum is a Cardiology focused EMR used by the majority of Canadian community-based Cardiologists. The AI Clinical Co Pilot for Cardiology, will also be deployed across WELL Diagnostic Centres, Canada’s largest cardiology network, providing support to cardiologists in over 40 locations across Ontario. This partnership positions Khure’s technology and HEALWELL at the forefront of AI-powered healthcare solutions, impacting the lives of countless patients.
To learn more about WELL Health’s new AI-powered co-pilot for cardiologists, please visit the full press release clicking the button below.
References
[1] https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29
[2] https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1
